Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 · New England Journal of Medicine · 6,623 citations
https://doi.org/10.1056/nejmoa1409077
K
Karl Swedberg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
690
Papers
100.8K
Citations
136
h-index
453
i10-index
Karl Swedberg is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Cardiac pacing and defibrillation studies. The author has an h-index of 136, co-authored 587 publications.
ORCID: 0000-0002-6358-2154Papers by this author
worksPredicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
2012 · European Heart Journal · 1,295 citations
https://doi.org/10.1093/eurheartj/ehs337
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
1993 · The Lancet · 1,234 citations
https://doi.org/10.1016/0140-6736(93)92930-r
Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
2007 · Journal of the American College of Cardiology · 944 citations
https://doi.org/10.1016/j.jacc.2007.02.067
Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
2002 · European Journal of Heart Failure · 454 citations
https://doi.org/10.1016/s1388-9842(01)00231-8
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
2018 · JACC Heart Failure · 422 citations
https://doi.org/10.1016/j.jchf.2018.02.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat